The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agree, the more tests the more options. Thanks for your view on pricing. I was trying to make the point, its not the end of the world if 10% is moved over to one of the other tests. :). Im very confident we will soon hear of good things..:).
the 75p profit was the 'expected' profit on the UK GOV orders. The first resulted in 'slightly better margin', but we weren't told the actual ammount.
If we supply the ABC-19 test to other parties, though, it works out much more profitable.
It's a great test to have in the Omega line up.
The abc-19 test is just 75p profit per test , so better we don't produce them and use the capacity for the £2.5 profit with most the other tests. but think Colin is obliged to...
And let us not forget... by the time April comes, and we're producing 2 Million tests a week, this RTC malarky makes up just 10% of that.
I've no doubt Colin and team will be able to find another test to divert that 200k per week towards.
The joys of a scalable production environment, that Omega have planned for from day one.
So in summary.
No new news. Only regurgitated known news.
The fundamentals are the same. As confirmed by Omega|:
https://twitter.com/OmegaDiagnostic/status/1354503879732424708
The ONLY thing that has changed is that Abingdon "expects that any future orders will be received via an application by the Company to future DHSC tender notices" instead of under the initial framework agreement.
Last I researched, the RTC was still setup by the UK GOV, the ABC-19 was funded by the UK GOV. The ABC-19 test is still the gold standard AB LFT. In a 'competitive' tender I'm sure it will fair well.
https://twitter.com/Shredz90/status/1354495395670470656 - Thanks Shredz
Abingdon have confirmed they are still producing the ABC-19 tests, in readiness for orders.
A nice summary of probable ODX production numbers too:
https://twitter.com/MerchantBanke18/status/1354520054210162690 - Thanks MerchantBanker
In fact one other thing that may have also changed is that news of MHRA approval for home use has been granted. One for further digging.
Thanks JADAM for the well reasoned posts. Nice to see you back.
Thanks, also, to BigJock36 for the continued dialogue with CK.
GLA